Is there a future for auto-allo HSCT in multiple myeloma?

Angela Dispenzieri

doi:10.1016/S1470-2045(11)70258-3

Is there a future for auto-allo HSCT in multiple myeloma?

Angela Dispenzieri

Hematology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1176-1177
Number of pages	2
Journal	The Lancet Oncology
Volume	12
Issue number	13
DOIs	https://doi.org/10.1016/S1470-2045(11)70258-3
State	Published - Dec 2011

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(11)70258-3

Cite this

@article{8bd5580da61849288508fe1474ca9814,

title = "Is there a future for auto-allo HSCT in multiple myeloma?",

author = "Angela Dispenzieri",

note = "Funding Information: I am supported in part by the US National Cancer Institute (grant numbers CA125614, CA107476, and CA111345 ) and the Predolin and JABBS foundations.",

year = "2011",

month = dec,

doi = "10.1016/S1470-2045(11)70258-3",

language = "English (US)",

volume = "12",

pages = "1176--1177",

journal = "The Lancet Oncology",

issn = "1470-2045",